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Calculation Skills: Blood Glucose Lowering Therapy in Adults with Type 2 Diabetes 
Approximately 90% of cases of diabetes are of Type 2 diabetes, where the body either 
becomes resistant to the effect of the insulin produced or produces inadequate amounts of 
insulin (Public Health England, 2014). Incidence of diabetes is rising, with 6% (2.7million) of 
people aged 17 years or over in England in 2013, diagnosed with diabetes. A range of 
complications are associated with type 2 diabetes, including retinopathy, neuropathy, 
nephropathy and cardiovascular disease (Diabetes UK, 2015). As such, the effective 
management of type 2 diabetes is essential and should be individualised and underpinned by 
patient education (National Institute of Health and Care Excellence [NICE], 2013).  
 
Question 1 
Based on the incidence figures above, what is the total population of people aged 17 years 
and over, on which these figures are based? 
 
Question 2 
Charlotte is a 46 year old administrator who was diagnosed with type 2 diabetes 10 months 
ago. Although classed as obese on diagnosis, she was receptive to the support given to assist 
in her weight loss and has maintained a normal weight for the past 4 months. However, despite 
making appropriate lifestyle changes, her HbA1c continues to range from 48-50 mmol/mol. It 
is agreed that she should commence drug therapy, which based on NICE (2015) guidance will 
be standard-release metformin.  
(i) The regime agreed is 500mg daily for 1 week, 500mg twice daily for one week and then 
500mg three times daily thereafter. How many 500mg tablets will need to be prescribed to 
complete the first 7 weeks of treatment? 
 
(ii) Metformin tablets are available in two pack sizes: 28-tab pack costing 87p and 84-tab pack 
costing £1.00. What will be the most cost-effective pack combination for this 7 week treatment 
period (assuming packs will not be split) whilst prescribing the least number of tablets over 
the required amount? 
 
Question 3 
Roger is a 31 year old retail manager who was diagnosed with type 2 diabetes 5 months ago. 
He has been unable to tolerate standard-release metformin and following an unsuccessful trial 
of modified-release metformin, it is agreed that sulfonylurea treatment is appropriate. 
 
Sulfonylurea Dose Cost 
Glibencamide 5mg daily adjusted according to 
response, max. 15mg daily 
2.5mg 28-tab pack £18.50 
5mg 28-tab pack 97p 
Gliclazide 40-80mg daily adjusted according to 
response up to 160mg single dose, 
max. 320mg daily in divided doses 
40mg 28-tab pack £3.36 
80mg 28-tab pack £1.04 
80mg 60-tab pack £2.23 
Glimepiride 1mg daily adjusted according to 
response, max. 4mg 
1mg 30-tab pack £1.20 
2mg 30-tab pack £1.12 
3mg 30-tab pack £7.25 
4mg 30-tab pack £1.33 
Glipizide 2.5-5mg daily, adjusted according to 
response up to 15mg single dose, max. 
20mg in divided doses 
5mg 56-tab pack £5.36 
Tolbutamide 0.5-1.5g (max. 2mg) in divided doses 500mg 28-tab pack £22.64 
 
Use the data presented in the table to answer the following questions. 
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(i)  If Roger is prescribed Glibencamide 5mg daily for 4 weeks and this was increased to a 
maintenance dose of 7.5mg daily, how many tablets will he have taken in a 16 week period 
(assuming a tablet combination which requires the least number of tablets to be taken)? 
 
 
(ii) If Roger’s prescribed regime was Tolbutamide at a maintenance dose of 1.5mg daily 
(divided into three equal doses), how many packs (un-split) would he need for the period 1st 
March 2016 to 31st July 2016? 
  
(iii) If Roger is prescribed Glimepiride with the following regime, assuming he has only 1mg 
tablets available to him in the first 3 weeks and 3mg tablets thereafter, what will be the cost of 
this 14 week treatment (assuming packs are not split)? 
 
Weeks 1 & 2 - 1mg daily 
Week 3 - 2mg daily 
Weeks 4-14 (inclusive) – 3mg daily 
 
 
(iv) What would be the cost difference for 2 months (assuming 30 days per month) treatment 
with a daily 160mg single dose of Glicazide or a daily dose of Glipizide 15mg?  
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Answers 
 
Question 1 
 
Based on the incidence figures above, what is the total population of people aged 17 years 
and over, on which these figures are based? 
 
6% = 2700,000 
1% = 2700,000 ÷ 6 = 450,000 
100% = 450,000 x 100 = 45,000,000 
 
Total population is 45 million 
 
 
Question 2 
 
(i) How many 500mg tablets will need to be prescribed to complete the first 7 weeks of 
treatment? 
 
Week 1: 1 tablet per day = 7 tablets 
Week 2: 2 tablets per day = 14 tablets 
Week 3 -7: 3 tablets per day = 21 tablets x 5 weeks = 105 tablets 
Total: 7 + 14 + 105 = 126 
 
(ii) What will be the most cost-effective pack combination for this 7 week treatment period 
(assuming packs will not be split) whilst prescribing the least number of tablets over the 
required amount? 
Required tablets = 126 
Possible combinations: 
5 x 28 pack (total 140 tablets) = 5 x 87p = £4.35 
1 x 84 pack + 2 x 28 pack (total 140 tablets) = £1.00 + (2 x 87p = £1.74) = £2.74 
2 x 84 pack (total 168 tablets) = £2.00 – this is the most cost-effective. 
 
Question 3 
 
(i)  If Roger was prescribed Glibencamide 5mg for 4 weeks and this was increased to a 
maintenance dose of 7.5mg, how many tablets will he have taken in a 16 week period 
(assuming a tablet combination which requires the least number of tablets to be taken)? 
 
1st 4 weeks = 1 (5mg) tablet daily x 28 days = 28 tablets 
Weeks 5-16 = (1 x 5mg tablet + 1 x 2.5mg tablet) x 84 days = 2 x 84 = 168 tablets 
Total tablets = 28 + 168 = 196  
 
 
Dilyse Nuttall 
 
(ii) If Roger’s prescribed regime was Tolbutamide at a maintenance dose of 1.5mg daily 
(divided into three equal doses), how many packs (un-split) would he need for the period 1st 
March 2016 to 31st July 2016? 
  
Number of days = 31 + 30 + 31 + 30 + 31 = 153 days 
Tablets per day = 3 
Total tablets required = 153 x 3 = 459 
Packs required = 459 ÷ 28 = 16.4 = 17 un-split packs 
 
 
(iii) If Roger is prescribed Glimepiride with the following regime, assuming he has only 1mg 
tablets available to him in the first 4 weeks and 3mg tablets thereafter, what will be the cost of 
this 14 week treatment (assuming packs are not split)? 
 
Weeks 1 & 2 - 1mg daily 
Week 3 - 2mg daily 
Weeks 4-14 (inclusive) – 3mg daily 
 
Weeks 1 & 2 = 14 1mg tablets + Week 3 = 14 1mg tablets = 28 tablets (so 1 x 30-tab pack) = 
£1.20 
 
Weeks 4 -14 = 1 x 3mg tablet x 77 days = 77 tablets (so 3 x 30-tab pack)  
3 x £7.25 = £21.75 
 
Total cost 1.20 + 21.75 = £22.95 
 
(iv) What would be the cost difference for 2 months (assuming 30 days per month) treatment 
with a daily 160mg single dose of Glicazide or a daily dose of Glipizide 15mg?  
 
Glicazide:  
Daily dose: 160mg = 2 x 80mg tablets 
60 days treatment = 2 x 60 = 120 tablets 
Packs required = 120 ÷ 60-tab pack = 2 
Cost = 2 x £2.23 = £4.46 
 
Glipizide: 
Daily dose: 15mg = 3 x 5mg tablets 
60 days treatment = 3 x 60 = 180 tablets 
Packs required = 180 ÷ 56-tab pack = 3.2 (4 un-split packs)  
Cost = 4 x £5.36 = £21.44 
 
Cost difference = 21.44 – 4.46 = £16.98 
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